Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.
Scope of the Report:
This report focuses on the Cystic Fibrosis (CF) Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Cystic Fibrosis (CF) Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Vertex Pharmaceuticals Incorporated
- Gilead
- AbbVie, Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Alaxia
- Merck & Co. Inc.
- AIT (Advanced Inhalation Therapies)
- ALLERGAN
- AstraZeneca
- Teva Pharmaceutical Industries Ltd
- Alcresta
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Pancreatic enzyme supplements
- Mucolytics
- Bronchodilators
- CFTR modulators
Market Segment by Applications, can be divided into
- Oral drugs
- Inhaled drugs
There are 15 Chapters to deeply display the global Cystic Fibrosis (CF) Therapeutics market.
Chapter 1, to describe Cystic Fibrosis (CF) Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cystic Fibrosis (CF) Therapeutics, with sales, revenue, and price of Cystic Fibrosis (CF) Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cystic Fibrosis (CF) Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cystic Fibrosis (CF) Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cystic Fibrosis (CF) Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cystic Fibrosis (CF) Therapeutics Market 2018, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Cystic Fibrosis (CF) Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Pancreatic enzyme supplements
1.2.2 Mucolytics
1.2.3 Bronchodilators
1.2.4 CFTR modulators
1.3 Market Analysis by Applications
1.3.1 Oral drugs
1.3.2 Inhaled drugs
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Vertex Pharmaceuticals Incorporated
2.1.1 Business Overview
2.1.1.1 Vertex Pharmaceuticals Incorporated Description
2.1.1.2 Vertex Pharmaceuticals Incorporated Headquarter, Main Business and Finance Overview
2.1.2 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Product Introduction
2.1.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.1.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.1.3 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.2 Gilead
2.2.1 Business Overview
2.2.1.1 Gilead Description
2.2.1.2 Gilead Headquarter, Main Business and Finance Overview
2.2.2 Gilead Cystic Fibrosis (CF) Therapeutics Product Introduction
2.2.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.2.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Gilead Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.3 AbbVie, Inc.
2.3.1 Business Overview
2.3.1.1 AbbVie, Inc. Description
2.3.1.2 AbbVie, Inc. Headquarter, Main Business and Finance Overview
2.3.2 AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Product Introduction
2.3.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.3.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.3.3 AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.4 Novartis AG
2.4.1 Business Overview
2.4.1.1 Novartis AG Description
2.4.1.2 Novartis AG Headquarter, Main Business and Finance Overview
2.4.2 Novartis AG Cystic Fibrosis (CF) Therapeutics Product Introduction
2.4.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.4.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Novartis AG Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.5 F. Hoffmann-La Roche Ltd
2.5.1 Business Overview
2.5.1.1 F. Hoffmann-La Roche Ltd Description
2.5.1.2 F. Hoffmann-La Roche Ltd Headquarter, Main Business and Finance Overview
2.5.2 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product Introduction
2.5.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.5.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.6 Alaxia
2.6.1 Business Overview
2.6.1.1 Alaxia Description
2.6.1.2 Alaxia Headquarter, Main Business and Finance Overview
2.6.2 Alaxia Cystic Fibrosis (CF) Therapeutics Product Introduction
2.6.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.6.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Alaxia Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.7 Merck & Co. Inc.
2.7.1 Business Overview
2.7.1.1 Merck & Co. Inc. Description
2.7.1.2 Merck & Co. Inc. Headquarter, Main Business and Finance Overview
2.7.2 Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Product Introduction
2.7.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.7.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.7.3 Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.8 AIT (Advanced Inhalation Therapies)
2.8.1 Business Overview
2.8.1.1 AIT (Advanced Inhalation Therapies) Description
2.8.1.2 AIT (Advanced Inhalation Therapies) Headquarter, Main Business and Finance Overview
2.8.2 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product Introduction
2.8.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.8.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.9 ALLERGAN
2.9.1 Business Overview
2.9.1.1 ALLERGAN Description
2.9.1.2 ALLERGAN Headquarter, Main Business and Finance Overview
2.9.2 ALLERGAN Cystic Fibrosis (CF) Therapeutics Product Introduction
2.9.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.9.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global ALLERGAN Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.10 AstraZeneca
2.10.1 Business Overview
2.10.1.1 AstraZeneca Description
2.10.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.10.2 AstraZeneca Cystic Fibrosis (CF) Therapeutics Product Introduction
2.10.2.1 Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
2.10.2.2 Cystic Fibrosis (CF) Therapeutics Product Information
2.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global AstraZeneca Cystic Fibrosis (CF) Therapeutics Market Share in 2017
2.11 Teva Pharmaceutical Industries Ltd
2.11.1 Business Overview
2.11.2 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product Introduction
2.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alcresta
2.12.1 Business Overview
2.12.2 Alcresta Cystic Fibrosis (CF) Therapeutics Product Introduction
2.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cystic Fibrosis (CF) Therapeutics Market Competition, by Manufacturer
3.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Cystic Fibrosis (CF) Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 Cystic Fibrosis (CF) Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Cystic Fibrosis (CF) Therapeutics Market Analysis by Regions
4.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales by Regions (2013-2018)
4.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue by Regions (2013-2018)
4.2 North America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 North America Cystic Fibrosis (CF) Therapeutics by Countries, Type, Application and Manufacturers
5.1 North America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
5.1.2 North America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America Cystic Fibrosis (CF) Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Cystic Fibrosis (CF) Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 Europe Cystic Fibrosis (CF) Therapeutics by Countries, Type, Application and Manufacturers
6.1 Europe Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe Cystic Fibrosis (CF) Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Cystic Fibrosis (CF) Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Cystic Fibrosis (CF) Therapeutics by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
7.1.3 China Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 South America Cystic Fibrosis (CF) Therapeutics by Countries, Type, Application and Manufacturers
8.1 South America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
8.1.2 South America Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America Cystic Fibrosis (CF) Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Cystic Fibrosis (CF) Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Cystic Fibrosis (CF) Therapeutics by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa Cystic Fibrosis (CF) Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Type
10.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Pancreatic enzyme supplements Sales Growth and Price
10.2.1 Global Pancreatic enzyme supplements Sales Growth (2013-2018)
10.2.2 Global Pancreatic enzyme supplements Price (2013-2018)
10.3 Mucolytics Sales Growth and Price
10.3.1 Global Mucolytics Sales Growth (2013-2018)
10.3.2 Global Mucolytics Price (2013-2018)
10.4 Bronchodilators Sales Growth and Price
10.4.1 Global Bronchodilators Sales Growth (2013-2018)
10.4.2 Global Bronchodilators Price (2013-2018)
10.5 CFTR modulators Sales Growth and Price
10.5.1 Global CFTR modulators Sales Growth (2013-2018)
10.5.2 Global CFTR modulators Price (2013-2018)
11 Global Cystic Fibrosis (CF) Therapeutics Market Segment by Application
11.1 Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Application (2013-2018)
11.2 Oral drugs Sales Growth (2013-2018)
11.3 Inhaled drugs Sales Growth (2013-2018)
12 Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.1 Global Cystic Fibrosis (CF) Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Cystic Fibrosis (CF) Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.4 South America Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cystic Fibrosis (CF) Therapeutics Market Forecast (2018-2023)
12.3 Cystic Fibrosis (CF) Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Cystic Fibrosis (CF) Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Cystic Fibrosis (CF) Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cystic Fibrosis (CF) Therapeutics Picture
Table Product Specifications of Cystic Fibrosis (CF) Therapeutics
Figure Global Cystic Fibrosis (CF) Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Cystic Fibrosis (CF) Therapeutics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Cystic Fibrosis (CF) Therapeutics by Types in 2017
Figure Pancreatic enzyme supplements Picture
Table Major Manufacturers of Pancreatic enzyme supplements
Figure Mucolytics Picture
Table Major Manufacturers of Mucolytics
Figure Bronchodilators Picture
Table Major Manufacturers of Bronchodilators
Figure CFTR modulators Picture
Table Major Manufacturers of CFTR modulators
Figure Cystic Fibrosis (CF) Therapeutics Sales Market Share by Applications in 2017
Figure Oral drugs Picture
Figure Inhaled drugs Picture
Figure United States Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cystic Fibrosis (CF) Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Vertex Pharmaceuticals Incorporated Headquarter, Established, Main Business and Finance Overview (2017)
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Product
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table Gilead Headquarter, Established, Main Business and Finance Overview (2017)
Table Gilead Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table Gilead Cystic Fibrosis (CF) Therapeutics Product
Table Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Gilead Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global Gilead Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table AbbVie, Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Product
Table AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global AbbVie, Inc. Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Product
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis AG Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global Novartis AG Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table F. Hoffmann-La Roche Ltd Headquarter, Established, Main Business and Finance Overview (2017)
Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product
Table F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table Alaxia Headquarter, Established, Main Business and Finance Overview (2017)
Table Alaxia Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table Alaxia Cystic Fibrosis (CF) Therapeutics Product
Table Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Alaxia Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global Alaxia Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table Merck & Co. Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Product
Table Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global Merck & Co. Inc. Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table AIT (Advanced Inhalation Therapies) Headquarter, Established, Main Business and Finance Overview (2017)
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table ALLERGAN Headquarter, Established, Main Business and Finance Overview (2017)
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Product
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global ALLERGAN Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Product
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales Market Share in 2017
Figure Global AstraZeneca Cystic Fibrosis (CF) Therapeutics Revenue Market Share in 2017
Table Teva Pharmaceutical Industries Ltd
Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics
Table Alcresta
Table Alcresta Cystic F
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
